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Performance testsAbstract A simple, rapid, and sensitive analytical procedure has been developed and validated for
the in vitro measurement of curcumin in samples from mucosae retention studies. Curcumin was
analyzed by HPLC using a C18 column with UV detection at 425 nm. The mobile phase was ace-
tonitrile and water (50:50 v/v) acidiﬁed with 2% acetic acid at a ﬂow rate of 1.2 mL min1. The
curve range was linear for the receptor solution concentration range 0.5–75 lg mL1. The speciﬁcity
showed no interference with the biological matrix and excipients of the acceptor media. Intra and
inter-day accuracy, and precision values were lower than 5% and were not statically different
(P< 0.05). Recoveries ranged from 99.7% to 108%. The limits of detection and quantitation were
11.61 and 500 ng mL1, respectively. The method is adequate to assay curcumin from esophageal
porcine samples, enabling the determination of penetration proﬁles for in situ gelling curcumin-
loaded liquid crystals by in vitro studies, and fulﬁlled the requirements for reliability and feasibility
for application to the quantitative analysis of curcumin in porcine esophageal mucosae.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Curcumin is a natural product isolated as a yellow pigment from the
rhizome of Curcuma longa L. (Sharma et al., 1990). This drug has
shown potential for use in treating cancer (Anand et al., 2008; Goel
et al., 2008; Zlotogorski et al., 2013) because it inhibits the nuclear
factor kappa beta (NF-kB), especially in oral squamous cancer cells
(OSCC) (Aggarwal et al., 2004), that is directly involved in tumorige-
nesis, (Richmond, 2002) angiogenesis, invasion tumors, and metastasis
(Ben-Neriah and Karin, 2011). Curcumin also has poor water solubil-
ity and low bioavailability, thus representing an interesting drug modelation of
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2 B. Fonseca-Santos et al.to be improved by nanotechnology (Ghalandarlaki et al., 2014; Sun
et al., 2012; Ahmad et al., 2015) for the non-invasive administration
of drugs (Mathias and Hussain, 2010), especially via the buccal route
(Calixto et al., 2014; Shojaei, 1998; Campisi et al., 2010).
The buccal route is attractive for the administration of drugs in
delivery systems, such as loaded-liquid crystalline systems (Calixto
et al., 2014; Salmazi et al., 2015), prolonging the residence time of
the dosage in the oral mucosa (Shojaei, 1998; Grabovac et al., 2005)
and enabling local treatment of malignant lesions (Nielsen et al.,
1998; Bhardwaj and Kumar, 2012; Hearnden et al., 2012). Liquid crys-
tals (LCs) are matter in a state that has properties between those of
conventional liquids and solid crystals (Malmsten, 2002). In other
words, LCs have the structural behavior and rigidity of a solid, com-
bined with the mobility, disorder, and ﬂuidity of an isotropic liquid
(Kato, 2008). By increasing the concentration of solvents, such as
water, in these systems, lamellar, hexagonal, and cubic liquid-
crystalline forms can be generated (Malmsten, 2007; Mezzenga, 2012).
LCs can be used as drug delivery systems because of the high ability
of poorly water-soluble drug solubilization (Malmsten, 2002), like cur-
cumin, besides showing interesting mucoadhesive properties being very
interesting to buccal administration to increasing the time retention of
LCs formulations.
Self-assembly systems display phase transformations and notable
in situ thickening after administration to body cavities, such as the
mouth. When in contact with the oral environment, LCs have the
ability to incorporate saliva, becoming a more viscous liquid-
crystalline mesophase (Malmsten, 2007) due to its transitional from
a lamellar phase structure to a hexagonal or cubic mesophase (Lee
et al., 2001; Boyd et al., 2006; Bruschi et al., 2008; Carvalho et al.,
2013) that can promote controlled release and, consequently, result
in the greatest mucoadhesion pharmaceutical form in the oral envi-
ronment (Malmsten, 2002, 2007; Bruschi and de Freitas, 2005;
Gilhotra et al., 2014). Due to their high viscosity, hexagonal and
cubic phases have been suggested as mucoadhesives (Carvalho
et al., 2013; Fonseca-Santos et al., 2015; Oyafuso et al., 2015), as well
as the incorporation of (muco)adhesive polymers such as chitosan
(Dhawan et al., 2004; Pendekal and Tegginamat, 2012) that can also
interact locally with oral tumor cells (He et al., 2010; Wu et al., 2012;
Yu et al., 2012).
The vertical diffusion cell, also known as the Franz cell, is widely
used for the drug release-rate testing of semisolids and other topical
formulations (Hanson and Heaney, 2013; Shah, 2005; Ng et al.,
2010). The dosage forms are placed in a donor area that then perme-
ates and/or diffuses through a membrane into the receptor solution,
from which samples are withdrawn periodically and analyzed for
drug concentrations (Hanson and Heaney, 2013). The experimental
conditions for drug release testing, such as acceptor media, types of
membrane, and usage of different animal tissue as models, depend
on the purpose of the experiments, i.e., whether the aim is quality
control (Ng et al., 2010), biopharmaceutical characterization
(Siewert et al., 2003), or bioavailability testing in order to decrease
or eliminate animal tests (Shah, 2005, 2001; Ng et al., 2010; Shah
et al., 2002).
Analytical methods, employed for the quantitative determination
of drugs in biological samples and pharmaceutical dosage forms
(Silva et al., 2014; Mattos et al., 2013; Chorilli et al., 2011a,b; Jain
et al., 2015; Dewani et al., 2015; Chiva Carvalho et al., 2013;
Carvalho et al., 2009), can inﬂuence the evaluation and interpretation
of bioavailability, bioequivalence, and pharmacokinetic data. It is,
therefore, essential to employ well-characterized and fully validated
analytical methods to give reliable results that can be interpreted with
satisfaction (Shah et al., 1992).
A variety of analysis techniques for the quantiﬁcation of total and
isolated curcuminoids in different matrices have been reported, espe-
cially spectrophotometric methods for the determination of total cur-
cuminoids (Kadam et al., 2013; Silva-Buzanello et al., 2015; Ahmed
et al., 2012). However, this approach cannot be used to quantifyPlease cite this article in press as: Fonseca-Santos, B. et al., A simple reversed phase
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have been developed for this purpose. High-pressure liquid chromatog-
raphy with UV detection (HPLC–UV) is the most common method for
the determination of curcuminoids and curcumin in turmeric samples,
biological samples, or dosage forms (Jadhav et al., 2007; Li et al., 2009;
Thorat and Jangle, 2013; Nascimento et al., 2012; Wichitnithad et al.,
2009; Jayaprakasha et al., 2002; Syed et al., 2015; Koop et al., 2013).
Due to the very labile characteristics of curcuminoids, C18 columns
are preferred for HPLC analysis (Khurana and Ho, 1988). These meth-
ods reported by HPLC–UV for curcuminoids, especially those in older
literature, have several disadvantages, including unsatisfactory separa-
tion times, poor resolution, complicated solvent mixtures with gradient
elution, and long analysis times.
The aim of this study was to develop and validate an analytical
method for evaluating the performance test of in situ gelling
curcumin-loaded liquid crystals.2. Experimental
2.1. Chemicals
Polyoxypropylene-(5)-polyoxyethylene-(20)-cetyl alcohol
(PPG-5-Ceteth-20) was purchased from Croda (Campinas,
Brazil). Oleic acid and sodium dodecyl sulfate were purchased
from Synth (Diadema, Brazil). Curcumin (77% purity), low
molecular weight chitosan (Ch), and poloxamer 407 (Po) were
purchased from Sigma Aldrich (St Louis, USA). HPLC grade
acetonitrile and methanol were purchased from J. T. Baker
(Mexico City, Mexico). Glacial acetic acid, sodium dihydrogen
phosphate, and sodium hydrogen phosphate were purchased
from Qhemis Hexis (Indaiatuba, Brazil). Ultrapure water was
obtained from a Milli-Q Direct Water Puriﬁcation System.
2.2. Chromatographic system and instrumentation
A Varian ProStar HPLC system was used for analyses, con-
sisting of two pumps (Solvent Delivery Module, model 210), a
ProStar 330 UV–vis PDA spectrophotometric detector (set at
425 nm), a ProStar 410 auto sampler (sample injection volume,
20 lL) and Timerline 101 column oven (set at 33 C). A
reverse-phase C18 column Luna (250 mm  4.6 mm i.d.
5 lm particle size) was used. The mobile phase was a 50:50
(v/v) mixture of acetonitrile and 2% acetic acid in water at a
ﬂow rate of 1.2 mL min1.
2.3. Standard and working solutions
Curcumin was dissolved in methanol in a 20.0 mL volumetric
ﬂask to a ﬁnal concentration of 1.0 mg mL1. The solution was
sonicated for 5 min in an ultrasonic bath and completed to the
ﬁnal volume. Working solutions (0.5–75.0 lg mL1) were pre-
pared by dilution of aliquots of the standard solution with
methanol (1.0 mg mL1) in a 5.0 mL volumetric ﬂask.
2.4. Validation methods
2.4.1. Linearity
To determine linearity, curcumin standard solution was
diluted in triplicate at concentrations ranging from 0.5 to
75.0 lg mL1 (working solutions). Linearity was evaluatedhigh-performance liquid chromatography (HPLC) method for determination of
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.014
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squares regression analysis and ANOVA test (a= 0.05).
2.4.2. Specificity and selectivity
The speciﬁcity of the method was determined by curcumin, the
acceptor media (buffer phosphate, pH 6.8 containing 0.5%
sodium dodecyl sulfate, SDS), and methanol extract mucosae
esophageal porcine (biological membrane used in permeation
and retention studies) to evaluate interference in the quantita-
tion of the drug.
2.4.3. Accuracy
To evaluate the accuracy of the method, a recovery experiment
was performed. Curcumin concentrations of 1.0, 50.0 and
70 lg mL1 were added to the matrix samples: phosphate buf-
fer (pH 6.8 containing SDS; acceptor media) and mucosae eso-
phageal methanolic extract. These results were expressed as
recovery data and values should be within the interval 80–
120% (Resoluc¸a˜o RE, 2003).
2.4.4. Precision
Intra and inter-day precision was analyzed by injecting cur-
cumin working solutions in triplicate (n= 3) at three concen-
trations (1.0, 50.0 and 70.0 lg mL1) over an interval of two
days between repeatability and intermediate precision tests
(Validation of Analytical Procedures, 2005). The results were
expressed as percentage of RSD and inter-day averages were
evaluated statically by Student’s t-test (tailed test, P< 0.05).
2.4.5. Limits of detection and quantitation
Limits of detection (LOD) and quantitation (LOQ) were deter-
mined using a calibration curve method according to ICH rec-
ommendations (Validation of Analytical Procedures, 2005).
The response standard deviation (RSD) was taken as the SD
of y-intercepts of the regression lines of the three calibration
curves. The LOD were calculated as follows:
LOD ¼ 10 r=S ð1Þ
where r is the standard deviation of the response, and S is the
slope of the calibration curve. Limit of quantitation (LOQ)
was determined as the ﬁrst concentration of calibration curves.
2.5. Liquid crystal preparation and characterization
LCs were prepared at room temperature by mixing oleic acid as
the oily phase (O), PPG-5-Ceteth-20 as the surfactant (S), and
water (W) containing 0.5% Ch and Po as the aqueous phase.
The samples contained the following O/S/W proportions:
(LC1) 3:4:3, (LC2) 1:2:2 and (LC3) 1:4:5. Sample LC1 was
diluted with artiﬁcial saliva (10:3) to generate the LC1d formu-
lation. These formulations were analyzed by polarized light
microscopy (PLM) to conﬁrm liquid crystal mesophases at
20 magniﬁcation. The artiﬁcial saliva is composed of sodium
phosphate dibasic anhydrous (802.9 mg), sodium phosphate
monobasic anhydrous (362.6 mg), 70% sorbitol solution
(42.7 g), potassium chloride (625.0 mg), sodium chloride
(865.0 mg), magnesium chloride hexahydrate (125.0 mg), cal-
cium chloride dehydrate (72.0 mg), methylparaben (1.8 g),
propylene glycol (10 mL) and puriﬁed water to 1000 mL
(Nakamoto, 1979).Please cite this article in press as: Fonseca-Santos, B. et al., A simple reversed phase
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The proposed analytical method was used to evaluate the con-
tent of curcumin retained in the porcine mucosa when
curcumin-loaded LCs were applied to the mucosa. A Hanson
MicroettePlus Franz diffusion cell (Chatsworth, USA) was
ﬁlled with a media volume of 7.0 mL (phosphate buffer, pH
6.8 containing 0.5% SDS) and stirred at 300 rpm at a temper-
ature of 37 ± 0.5 C.
Porcine mucosa esophageal tissue was treated with buffer
phosphate for 5 min, then ﬁxed to the diffusion cell. Formula-
tions were placed (600 mg) above the membrane. The experi-
ment was carried out with curcumin-loaded LC1
(5.0 mg g1) and a formulation diluted to 10% with artiﬁcial
saliva (LC1d), and the results were compared to the release
proﬁle of curcumin dissolved in oleic acid as a control. During
the test, media aliquots of 1.0 mL were withdrawn at intervals
(0.5, 1, 2, 4, 8 and 12 h) using a Hanson AutoPlusTM MultiﬁllTM
autosampler (Chatsworth, USA). The aliquots were ﬁltered
through 0.45 lm PTFE disk ﬁlters and then injected into
HPLC.
The extraction of curcumin from the retained pig esopha-
geal mucosa was carried out according to an adapted method
(Mazzarino et al., 2015). After 12 h of ex vivo permeation, the
mucosa was removed from the Franz cell and the area of tis-
sue exposed to permeation was cleaned with cotton dipped in
methanol, and then the tissue was cut and perforated. The
fragments obtained were triturated with 4 mL of methanol
in a tissue homogenizer at 10,000 rpm for 2 min to achieve
total dispersion of the mucosa. The resulting suspension
was sonicated in an ultrasonic bath for 50 min to break the
cells.
The homogenate was centrifuged at 4000 rpm for 10 min.
The obtained supernatant solution was ﬁltered into a 5 mL
volumetric ﬂask and the volume completed with methanol.
The solution was ﬁltered through 0.45 lm PTFE disk ﬁlters
and injected into HPLC for analysis. Extractions were per-
formed from the mucosa of each diffusion cell (n= 6) and
are expressed as percentages. All average values of retention
were tested by ANOVA following Tukey’s post hoc test
(a= 0.05).3. Results and discussion
3.1. Validation studies
3.1.1. Linearity
Statistical analysis, using least-squares regression analysis of
curcumin assay results in the range 0.5–75 lg mL1, gave a
linear regression equation for the three calibration curves
for curcumin of: y= 0.002027x  0.000228, r= 0.999859
(Fig. 1). ANOVA of regression showed an F-critical value
of 6.0993  1036 and an F-tabulated value of 80768.6, which
indicated a signiﬁcant regression (because F-critical
value < F-tabulated value). According to the validation crite-
ria adopted, this method was linear over the whole tested
concentration range. The calibration curves are shown in
Fig. 1 and ANOVA is shown in Table 1. The validity of
the assay was veriﬁed by means of ANOVA, which showed
that there is linear regression with no deviation from linearity
(P< 0.05).high-performance liquid chromatography (HPLC) method for determination of
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.014
Figure 1 Calibration curves of curcumin at concentrations of
0.5–75 lg mL1 in methanol.
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The chromatograms in Fig. 2 show good peak resolutions,
indicating the high speciﬁcity and selectivity of this method.
The resolutions (R) of peaks were 2.2 and 3.0 between peaks
2/1 and 3/2, respectively, indicating a high degree of peak sep-
aration (R> 2). The chromatogram showed three peaks and
was reported by Jayaprakasha et al. (2002), where the major
peak was attributed to curcumin (Goel et al., 2008) and two
minor peaks were identiﬁed as demethoxycurcumin (Anand
et al., 2008) and bisdemethoxycurcumin (Sharma et al., 1990)
by co-injection of standards. These authors conﬁrmed the
compounds associated with elution peaks by 1H and 13C
NMR analysis.
The method developed by these authors was similar to that
developed in this work; however, the chromatographic condi-
tions were slightly different with regard to mobile phase pro-
portions (acetonitrile/water acidiﬁed with 2% acetic acid;
60:40 vs. 50:50 v/v in this work), the length of the C18 column
(150 mm vs. 300 mm in this work), and the solvent ﬂow rate
(2 mL min1 vs. 1.2 mL min1 in this work). The total chro-
matographic analysis time was 16 min per sample, with cur-
cumin, desmethoxycurcumin, and bisdesmethoxycurcumin
eluting at retention times of 13.6, 12.1 and 10.8 min, respec-
tively (Wichitnithad et al., 2009). However, chromatographic
analysis with a C18 column of 200 mm length would generate
an analysis time greater than 15 min. Therefore, our method
used the small changes mentioned above to achieve the best
peak resolution and a shorter analysis time.
The chromatogram of curcumin exhibited a characteristic
peak (Goel et al., 2008) at a retention time (tR) of 11.5 min,
and two minor peaks at a tR of 9.5 and 10.5 min, reported in
the literature as bisdesmethoxycurcumin and desmethoxycur-
cumin, respectively (Wichitnithad et al., 2009) (Fig. 2A). TheTable 1 ANOVA for simple linear regression.
Model d.f. Sum of squares
Regression 1 0.060102483
Residue 19 1.41385  1005
Total 20 0.060116621
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dures in quality control. The methodology was selective,
because no interfering signals were detected at the tR of accep-
tor media (phosphate buffer, pH 6.8) and mucosae methanolic
extract, and none interfered with curcumin detection (Fig. 2B).
3.1.3. Accuracy
Curcumin working solution and spiked samples (methanol,
phosphate buffer with 0.5 DSD and mucosae extract) were for-
tiﬁed at three concentrations (1.0, 50.0 and 70.0 lg mL1) by
diluting aliquots of the standard solution (1.0 mg mL1). Each
replicate was injected into the C18 column and peak areas were
obtained. These values were substituted into the regression line
equation to calculate the recovered concentrations of the sam-
ples. Accuracy is reported in Table 2 as a percentage recovery
relative to the known amount of curcumin in the samples. The
recovery values were within the conﬁdence interval of 80–
120%.
3.1.4. Precision
The intra-day precision was analyzed by injecting curcumin
working solutions in triplicate at 1.0, 50.0 and 70.0 lg mL1,
corresponding to low, average, and high concentrations in
the calibration curve range, respectively. The inter-day preci-
sion was analyzed by injecting each concentration three times
(n= 3) on two consecutive days. The standard deviation (SD)
and RSD were calculated for each sample (Table 3). The low
values of RSD (<2%) reﬂected the high precision of the
method and the P-value (<0.05) showed no mean signiﬁcance.
3.1.5. LOD and LOQ
The LOQ value was taken as the lowest concentration of cur-
cumin in the acceptor media that could be quantitatively mea-
sured. The LOD was 11.61 ng mL1 and LOQ was
0.5 lg mL1.
3.2. Liquid crystal preparations and characterization
Fig. 3A shows that it was possible to obtain an optically trans-
parent liquid system (OPCLS) when the concentrations of S,
O, and W were 40%, 30–70%, and above 50–70%, respec-
tively, and a minor region with 30%, 50–70% and 70%,
respectively. The transparent semisolid system (OPCSS) was
formed when concentrations of S, O, and W were 25–40–
30%, 5–25%, and 45–55%, respectively. Emulsion systems
were obtained in regions where concentrations of S, O, and
W were below 5–20%, 5–70%, and 85-95%, respectively.
Phase separation occurred in a large proportion of the formu-
lations, in two distinct regions: the ﬁrst region was formed
when the concentrations of S, O, and W were greater than
55–100%, 5–40%, and below 5–40%, respectively; the secondMean squares F-tabulated F-critical
0.060102 80768.6 6.1  1036
7.44  1007
high-performance liquid chromatography (HPLC) method for determination of
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Figure 2 Chromatograms of curcumin (50 lg mL1), blank methanol, and buffer phosphate as acceptor media and mucosae methanolic
extract, fortiﬁed or unfortiﬁed.
Table 2 Accuracy of curcumin at different concentrations (1.0, 50.0 and 70.0 lg mL1) in matrices (methanol, phosphate buffer with
0.5 DSD, and mucosae extract).
Matrix Theoretical concentration (lg mL1) Experimental concentration (lg mL1) RSD (%) Recovery (%)
Methanol 1.0 1.01 ± 0.02 1.98 101.0 ± 2.0
50.0 50.3 ± 0.05 0.10 100.7 ± 0.1
70.0 70.4 ± 0.7 0.30 100.0 ± 0.1
Phosphate buﬀer w/DSD 1.0 1.02 ± 0.03 2.94 102.0 ± 3.0
50.0 50.12 ± 0.11 0.22 100.2 ± 0.2
70.0 69.80 ± 0.09 0.13 99.7 ± 0.13
Mucosae extract 1.0 1.08 ± 0.03 2.78 108.0 ± 3.0
50.0 50.10 ± 0.59 1.18 100.4 ± 1.18
70.0 71.00 ± 0.9 1.41 101.4 ± 1.28
Determination of in situ gelling curcumin-loaded liquid crystals 5
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Figure 3 (A) Ternary phase diagram of PPG-5-CETETH-20, oleic acid, and aqueous phase (0.5% chitosan and poloxamer 407); (B)
macroscopic appearance and MPL of LC1, LC2, and LC3 formulations; and (C) photomicrographs of LC1 diluted with artiﬁcial saliva to
10% (d10), 20% (d20), and 30% (LC1d).
Table 3 Intra- and inter-day of curcumin at different concentrations (1.0, 50.0 and 70.0 lg mL1).
Theoretical concentration (lg mL1) Intra- and inter-day precision P-valuec
Experimental concentration (lg mL1)a RSD (%)b Recovery (%)a
Intra-day Inter-day Intra-day Inter-day Intra-day Inter-day
1.0 1.01 ± 0.02 1.01 ± 0.01 1.98 1.25 101.0 ± 2.0 100.8 ± 1.3 0.5000
50.0 50.3 ± 0.05 50.7 ± 0.61 0.1 1.20 100.7 ± 0.1 101.4 ± 1.22 0.2576
70.0 70.4 ± 0.7 70.03 ± 0.208 0.3 0.99 100.0 ± 1.0 100.6 ± 0.3 0.2168
a Mean and SD of samples.
b Triplicate in two different days.
c Student’s t-test with signiﬁcance level of 95%.
6 B. Fonseca-Santos et al.region was formed when the concentrations of S, O, and W
were below 40%, 50–100%, and 10–100%, respectively.
Based on the ternary phase diagram, formulation LC1, a
liquid formulation composed of 40% (w/w) PPG-5-
CETETH-20, 30% (w/w) oleic acid, and 30% (w/w) aqueous
phase (chitosan and PO 407 at 0.5%), was selected as the liq-
uid crystal precursor system because its liquid phase facilitated
buccal administration (e.g., by syringe) (Bruschi et al., 2008).
Both LC2 and LC3 were semisolid formulations composed
of 40% PPG-5-CETETH-20, 20% and 10% oleic acid, and
40% and 50% of aqueous phase (chitosan and PO 407 atPlease cite this article in press as: Fonseca-Santos, B. et al., A simple reversed phase
in situ gelling curcumin-loaded liquid crystals in in vitro performance tests. Arabian0.5%), respectively. These formulations were not adequate
for buccal administration due to their poor syringeability.
Moreover, LC1 is located in a phase transition region.
Thus, when diluted with artiﬁcial saliva, its viscosity increased
in situ. This can be observed in the dilution line in the diagram
in Fig. 3A.
Carvalho et al. (2013) previously developed a phase dia-
gram consisting of oleic acid as the oil phase, PPG-5-
CETETH-20 as the surfactant, and water as the aqueous
phase. This study also resulted in different regions, but
reported a lower region of transparent viscous systems,high-performance liquid chromatography (HPLC) method for determination of
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.014
Figure 4 Bar chart of curcumin retained (%) in mucosae
esophageal tissue obtained from retention studies after 12 h in
oleic acid, lamellar liquid crystal (LC1), and in situ gelling liquid
crystal (LC1d) *P> 0.05.
Determination of in situ gelling curcumin-loaded liquid crystals 7perhaps due to the absence of mucoadhesive polymers such as
chitosan and poloxamer, which are present in the diagram in
Fig. 3A. Such polymers may have thickening properties
(Chattopadhyay and Inamdar, 2010), changing the rheological
properties of these systems and leading to an increase in the
regions of viscous systems in the diagram.
Using the MPL technique, Malta crosses were observed in
the photomicrograph of LC1, suggesting that a lamellar liquid
crystalline mesophase had formed (Chorilli et al., 2011c).
Thus, the LC2 and LC3 photomicrographs showed striated
structures that may be more organized structures typical of a
hexagonal liquid crystalline mesophase (Carvalho et al.,
2013, 2010), as shown in Fig. 3B. When, LC1 was diluted with
artiﬁcial saliva in increasing proportions (10%, 20%, and
30%), resulting in LC1d10%, LC1d20% and LC1d, respec-
tively, the photomicrographs showed striated structures that
might be the more organized structures typical of a hexagonal
liquid crystalline mesophase (Salmazi et al., 2015). The results
for these phase transitions are shown in Fig. 3C.
Therefore, these results demonstrated that LC1 behaved as
a precursor of a LC system and was able to form a strong LC
mesophase with the incorporation of artiﬁcial saliva. This tran-
sition could be attributed to an increase in the packing con-
straint in the hydrophilic core of PPG-5-CETETH-20, which
reduced the interfacial curvature of the aggregate. Moreover,
the subsequent hydration of the surfactant generated a large
repulsive force between the head groups of the surfactant,
increasing the distances between lamellae (Carvalho et al.,
2010). This resulted in the formation of different liquid crys-
talline structures (Mezzenga, 2012).
3.2.1. Method applicability
During pharmaceutical development, it is appropriate to
employ in vitro release or permeation studies to select formula-
tions that can provide adequate therapeutic activity. Drug
release studies provide valuable data on the structural charac-
teristics of the vehicle and its ability to release the drug.
LC phases have received considerable attention due to their
potential as drug delivery systems. Cubic and hexagonal
phases provide a slow drug release matrix (Mezzenga et al.,
2005; Ubbink et al., 2008) when compared with lamellae
phase, which has a rapid drug release matrix (Farkas et al.,
2000; Makai et al., 2003).
Recently, Martiel et al. (2015) published work that
explained controlled release from LCs, detailing the inﬂuence
of drug hydrophobicity and oil-surfactant type on this prop-
erty. The authors summarized that partition coefﬁcients of
drugs and the ability of the drug to diffuse through the hydro-
carbon tail region were important. This phenomenon was
inﬂuenced by the bulkiness of the drug, the oil-type, and by
either chain stiffening (Martiel et al., 2015). The optimal struc-
tural control was obtained by combining a drug with high
hydrophobicity with LCs (Martiel et al., 2015), which may
not be true for curcumin due to its poor-water solubility.
Fig. 4 shows the cumulative percentage in the esophageal
mucosal tissue after a 12 h ex vivo test. Statistical analysis
showed that there were differences between the mean
(P> 0.05) percentages of retention for the formulations. The
retentions were approximately 3%, 15%, and 10% for the con-
trol, LC1, and LC1d, respectively. The lamellar phase reten-
tion values were greater than hexagonal systems, whichPlease cite this article in press as: Fonseca-Santos, B. et al., A simple reversed phase
in situ gelling curcumin-loaded liquid crystals in in vitro performance tests. Arabiancould be related to the similarity of the lamellar liquid-
crystalline structure with the cell membrane leading to
enhanced interactions between them and causing the release
of tissue target from this interaction bio-nanodevice (Nel
et al., 2009; Liu and Wang, 2014). In addition, slow release
and high-capacity carrying of hydrophobic drugs, such as anti-
tumor drugs, into liquid-crystal systems, is particularly inter-
esting for cancer therapy, where the cytotoxicity of
anticancer drugs can be improved.
4. Conclusions
The HPLC method presented here can be considered suitable for ana-
lytical determination of curcumin concentrations for in vitro perfor-
mance tests. The method was capable of detecting low
concentrations of curcumin in the diffusion cell acceptor media, and
the calibration curve was linear over the concentration range. The val-
idation process also showed high selectivity and speciﬁcity, since there
was no interference between the curcumin peak and media or mucosae
components. The methodology was accurate and precise as observed
from the recovery and RSD values. The analytical procedure had a
15 min chromatographic run time, which allowed the analysis of a
large number of samples in a short period of time. Retention studies
showed higher concentrations on mucosae tissue to lamellar meso-
phase than hexagonal mesophase.
Designed LCs showed in situ gelling properties caused by the addi-
tion of artiﬁcial saliva. This artiﬁcial saliva caused the formation of a
lamellae mesophase, transforming into hexagonal liquid crystalline
formulations with mucoadhesive properties (data not shown).
This paper proposes a HPLC method to quantify curcumin in per-
formance in vitro assays for LCs containing curcumin; however, this
methodology can be applied to other pharmaceutical dosage forms
intended for buccal release of curcumin.
Disclosure
The authors report no conﬂict of interests in this work.
Acknowledgments
This work was ﬁnancially supported by Fundac¸a˜o de Amparo
a` Pesquisa do Estado de Sa˜o Paulo (FAPESP), grant
2013/03746-3, Coordination for the Improvement of Higherhigh-performance liquid chromatography (HPLC) method for determination of
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.014
8 B. Fonseca-Santos et al.Education Personnel (CAPES) for research fellowships, and
Programa de Apoio ao Desenvolvimento Cientı´ﬁco (PADC-
FCF-UNESP).
References
Aggarwal, S., Takada, Y., Singh, S., Myers, J.N., Aggarwal, B.B.,
2004. Inhibition of growth and survival of human head and neck
squamous cell carcinoma cells by curcumin via modulation of
nuclear factor-kappaB signaling. Int. J. Cancer 111 (5), 679–692.
Ahmad, M.Z., Alkahtani, S.A., Akhter, S., Ahmad, F.J., Ahmad, J.,
Akhtar, M.S., et al, 2015. Progress in nanotechnology-based drug
carrier in designing of curcumin nanomedicines for cancer therapy:
current state-of-the-art. J. Drug Target., 1–21
Ahmed, K., Li, Y., McClements, D.J., Xiao, H., 2012. Nanoemulsion-
and emulsion-based delivery systems for curcumin: encapsulation
and release properties. Food Chem. 132 (2), 799–807.
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A.B., Aggar-
wal, B.B., 2008. Curcumin and cancer: an ‘‘old-age” disease with an
‘‘age-old” solution. Cancer Lett. 267 (1), 133–164.
Ben-Neriah, Y., Karin, M., 2011. Inﬂammation meets cancer,
with NF-kappaB as the matchmaker. Nat. Immunol. 12 (8),
715–723.
Bhardwaj, V., Kumar, M.N.V.R., 2012. Drug delivery systems to ﬁght
cancer. In: Siegel, R.A., Rathbone, M.J., Siepmann, J. (Eds.),
Fundamentals and Applications of Controlled Release Drug
Delivery. Advances in Delivery Science and Technology. Springer,
New York, pp. 493–516.
Boyd, B.J., Whittaker, D.V., Khoo, S.M., Davey, G., 2006. Lyotropic
liquid crystalline phases formed from glycerate surfactants as
sustained release drug delivery systems. Int. J. Pharm. 309 (1–2),
218–226.
Bruschi, M.L., de Freitas, O., 2005. Oral bioadhesive drug delivery
systems. Drug Dev. Ind. Pharm. 31 (3), 293–310.
Bruschi, M.L., de Freitas, O., Lara, E.H., Panzeri, H., Gremiao, M.P.,
Jones, D.S., 2008. Precursor system of liquid crystalline phase
containing propolis microparticles for the treatment of periodontal
disease: development and characterization. Drug Dev. Ind. Pharm.
34 (3), 267–278.
Calixto, G., Bernegossi, J., Fonseca-Santos, B., Chorilli, M., 2014.
Nanotechnology-based drug delivery systems for treatment of oral
cancer: a review. Int. J. Nanomed. 9 (1), 3719–3735.
Campisi, G., Paderni, C., Saccone, R., Di Fede, O., Wolff, A.,
Giannola, L.I., 2010. Human buccal mucosa as an innovative site
of drug delivery. Curr. Pharm. Des. 16 (6), 641–652.
Carvalho, F., Barbi, M.d.S., Gremia˜o, M., 2009. LC evaluation of
in vitro release of AZT from microemulsions. Chroma 69 (2),
207–211.
Carvalho, F.C., Barbi, M.S., Sarmento, V.H., Chiavacci, L.A., Netto,
F.M., Gremiao, M.P., 2010. Surfactant systems for nasal zidovu-
dine delivery: structural, rheological and mucoadhesive properties.
J. Pharm. Pharmacol. 62 (4), 430–439.
Carvalho, F.C., Campos, M.L., Peccinini, R.G., Gremiao, M.P., 2013.
Nasal administration of liquid crystal precursor mucoadhesive
vehicle as an alternative antiretroviral therapy. Eur. J. Pharm.
Biopharm.: Off. J. Arbeitsgemeinschaft fur Pharmazeutische Ver-
fahrenstechnik eV 84 (1), 219–227.
Chattopadhyay, D.P., Inamdar, M.S., 2010. Aqueous behaviour of
chitosan. Int. J. Polym. Sci. 2010.
Chiva Carvalho, F., Leandro Campos, M., Goncalves Peccinini, R.,
Daﬂon Gremiao, M.P., 2013. An HPLC–UV method for the
quantiﬁcation of zidovudine in rat plasma. Curr. Pharm. Anal. 9
(4), 340–346.
Chorilli, M., Bonﬁlio, R., da Silva, Chicarelli R., Nunes Salgado, H.
R., 2011a. Development and validation of an analytical method by
RP-HPLC for quantiﬁcation of sibutramine hydrochloride in
pharmaceutical capsules. Anal. Methods 3 (4), 985–990.Please cite this article in press as: Fonseca-Santos, B. et al., A simple reversed phase
in situ gelling curcumin-loaded liquid crystals in in vitro performance tests. ArabianChorilli, M., Bonﬁlio, R., Louvandini, C.R., Gonc¸alves, F.A.R.M.,
Salgado, H.R.N., 2011b. Development and Validation of an LC-
MS/MS method for quantitative analysis of mirtazapine in human
plasma. Am. J. Anal. Chem. 02 (06), 650–657.
Chorilli, M., Prestes, P.S., Rigon, R.B., Leonardi, G.R., Chiavacci, L.
A., Sarmento, V.H.V., et al, 2011c. Structural characterization and
in vivo evaluation of retinyl palmitate in non-ionic lamellar liquid
crystalline system. Colloids Surf., B 85 (2), 182–188.
Dewani, A.P., Dabhade, S.M., Bakal, R.L., Gadewar, C.K., Chande-
war, A.V., Patra, S., 2015. Development and validation of a novel
RP-HPLC method for simultaneous determination of paracetamol,
phenylephrine hydrochloride, caffeine, cetirizine and nimesulide in
tablet formulation. Arab. J. Chem. 8 (4), 591–598.
Dhawan, S., Singla, A.K., Sinha, V.R., 2004. Evaluation of mucoad-
hesive properties of chitosan microspheres prepared by different
methods. AAPS PharmSciTech. 5 (4), e67.
Farkas, E., Zelko´, R., Ne´meth, Z., Pa´linka´s, J., Marton, S., Ra´cz, I.,
2000. The effect of liquid crystalline structure on chlorhexidine
diacetate release. Int. J. Pharm. 193 (2), 239–245.
Fonseca-Santos, B., Gremia˜o, M.P.D., Chorilli, M., 2015. Nanotech-
nology-based drug delivery systems for the treatment of Alzhei-
mer’s disease. Int. J. Nanomed. 10, 4981–5003.
Ghalandarlaki, N., Alizadeh, A.M., Ashkani-Esfahani, S., 2014.
Nanotechnology-applied curcumin for different diseases therapy.
BioMed. Res. Int. 2014, 23.
Gilhotra, R.M., Ikram, M., Srivastava, S., Gilhotra, N., 2014. A
clinical perspective on mucoadhesive buccal drug delivery systems.
J. Biomed. Res. 28 (2), 81–97.
Goel, A., Kunnumakkara, A.B., Aggarwal, B.B., 2008. Curcumin as
‘‘Curecumin”: from kitchen to clinic. Biochem. Pharmacol. 75 (4),
787–809.
Grabovac, V., Guggi, D., Bernkop-Schnurch, A., 2005. Comparison of
the mucoadhesive properties of various polymers. Adv. Drug Deliv.
Rev. 57 (11), 1713–1723.
Hanson, R., Heaney, J., 2013. A primer on automating the vertical
diffusion cell (VDC). Dissolution Technol. 20 (2), 40–43.
He, C., Hu, Y., Yin, L., Tang, C., Yin, C., 2010. Effects of particle size
and surface charge on cellular uptake and biodistribution of
polymeric nanoparticles. Biomaterials 31 (13), 3657–3666.
Hearnden, V., Sankar, V., Hull, K., Juras, D.V., Greenberg, M., Kerr,
A.R., et al, 2012. New developments and opportunities in oral
mucosal drug delivery for local and systemic disease. Adv. Drug
Deliv. Rev. 64 (1), 16–28.
Jadhav, B.K., Mahadik, K.R., Paradkar, A.R., 2007. Development
and validation of improved reversed phase-HPLC method for
simultaneous determination of curcumin, demethoxycurcumin and
bis-demethoxycurcumin. Chroma 65 (7–8), 483–488.
Jain, P.S., Bobade, K.D., Bari, P.R., Girase, D.S., Surana, S.J., 2015.
Development and validation of analytical method for Naftopidil in
human plasma by LC–MS/MS. Arab. J. Chem. 8 (5), 648–654.
Jayaprakasha, G.K., Jagan Mohan Rao, L., Sakariah, K.K., 2002.
Improved HPLC method for the determination of curcumin,
demethoxycurcumin, and bisdemethoxycurcumin. J. Agric. Food
Chem. 50 (13), 3668–3672.
Kadam, P.V., Bhingare, C.L., Nikam, R.Y., Pawar, S.A., 2013.
Development and validation of UV Spectrophotometric method
for the estimation of Curcumin in cream formulation. Pharm.
Methods 4 (2), 43–45.
Kato, T., 2008. Liquid Crystalline Functional Assemblies and Their
Supramolecular Structures. Springer, New York.
Khurana, A., Ho, C.-T., 1988. High performance liquid chromato-
graphic analysis of curcuminoids and their photo-oxidative decom-
position compounds in Curcuma Longa L. J. Liq. Chromatogr. 11
(11), 2295–2304.
Koop, H., de Freitas, R., de Souza, L., Martinez, G., Silveira, J.M.,
2013. Development and validation of a RP-HPLC–PDA method
for determination of curcuminoids in microemulsions. Chroma 76
(15–16), 1041–1048.high-performance liquid chromatography (HPLC) method for determination of
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.014
Determination of in situ gelling curcumin-loaded liquid crystals 9Lee, J., Young, S.A., Kellaway, I.W., 2001. Water quantitatively
induces the mucoadhesion of liquid crystalline phases of glyceryl
monooleate. J. Pharm. Pharmacol. 53 (5), 629–636.
Li, J., Jiang, Y., Wen, J., Fan, G., Wu, Y., Zhang, C., 2009. A rapid
and simple HPLC method for the determination of curcumin in rat
plasma: assay development, validation and application to a
pharmacokinetic study of curcumin liposome. Biomed. Chro-
matogr. 23 (11), 1201–1207.
Liu, X., Wang, S., 2014. Three-dimensional nano-biointerface as a new
platform for guiding cell fate. Chem. Soc. Rev. 43 (8), 2385–2401.
Makai, M., Csa´nyi, E., Ne´meth, Z., Pa´linka´s, J., Er}os, I., 2003.
Structure and drug release of lamellar liquid crystals containing
glycerol. Int. J. Pharm. 256 (1–2), 95–107.
Malmsten, M., 2002. Surfactants and Polymers in Drug Delivery.
Infoma Healthcare, New York, 348p.
Malmsten, M., 2007. Phase transformations in self-assembly systems
for drug delivery applications. J. Dispersion Sci. Technol. 28 (1),
63–72.
Martiel, I., Baumann, N., Vallooran, J.J., Bergfreund, J., Sagalowicz,
L., Mezzenga, R., 2015. Oil and drug control the release rate from
lyotropic liquid crystals. J. Control. Release 204, 78–84.
Mathias, N.R., Hussain, M.A., 2010. Non-invasive systemic drug
delivery: developability considerations for alternate routes of
administration. J. Pharm. Sci. 99 (1), 1–20.
Mattos, A.C.d., Khalil, N.M., Mainardes, R.M., 2013. Development
and validation of an HPLC method for the determination of
ﬂuorouracil in polymeric nanoparticles. Braz. J. Pharm. Sci. 49,
117–126.
Mazzarino, L., Loch-Neckel, G., Bubniak, L.D.S., Mazzucco, S.,
Santos-Silva, M.C., Borsali, R., et al, 2015. Curcumin-loaded
chitosan-coated nanoparticles as a new approach for the local
treatment of oral cavity cancer. J. Nanosci. Nanotechnol. 15 (1),
781–791.
Mezzenga, R., 2012. Physics of self-assembly of lyotropic liquid
crystals. In: Garti, N., Somasundaran, P., Mezzenga, R. (Eds.),
Self-assembled Supramolecular Architectures: Lyotropic Liquid
Crystals. Wiley, Hoboken, pp. 1–20.
Mezzenga, R., Schurtenberger, P., Burbidge, A., Michel, M., 2005.
Understanding foods as soft materials. Nat. Mater. 4 (10), 729–740.
Nakamoto, R.Y., 1979. Use of a saliva substitute in postradiation
xerostomia. J. Prosthet. Dent. 42 (5), 539–542.
Nascimento, T.C.F.d., Casa, D.M., Dalmolin, L.F., de Mattos, A.C.,
Khalil, N.M., Mainardes, R.M., 2012. Development and validation
of an HPLC method using ﬂuorescence detection for the quanti-
tative determination of curcumin in PLGA and PLGA-PEG
nanoparticles. Curr. Pharm. Anal. 8 (4), 324–333.
Nel, A.E., Madler, L., Velegol, D., Xia, T., Hoek, E.M.V., Somasun-
daran, P., et al, 2009. Understanding biophysicochemical interac-
tions at the nano-bio interface. Nat. Mater. 8 (7), 543–557.
Ng, S.-F., Rouse, J., Sanderson, F., Meidan, V., Eccleston, G., 2010.
Validation of a static Franz diffusion cell system for in vitro
permeation studies. AAPS PharmSciTech. 11 (3), 1432–1441.
Nielsen, L.S., Schubert, L., Hansen, J., 1998. Bioadhesive drug
delivery systems. I. Characterisation of mucoadhesive properties
of systems based on glyceryl mono-oleate and glyceryl monoli-
noleate. Eur. J. Pharm. Sci.: Off. J. Eur. Federation Pharm. Sci. 6
(3), 231–239.
Oyafuso, M.H., Carvalho, F.C., Chiavacci, L.A., Gremia˜o, M.P.D.,
Chorilli, M., 2015. Design and characterization of silicone and
surfactant based systems for topical drug delivery. J. Nanosci.
Nanotechnol. 15 (1), 817–826.
Pendekal, M.S., Tegginamat, P.K., 2012. Development and charac-
terization of chitosan-polycarbophil interpolyelectrolyte complex-
based 5-ﬂuorouracil formulations for buccal, vaginal and rectal
application. Daru: J. Faculty Pharm., Tehran Univ. Med. Sci. 20
(1), 67.
Resoluc¸a˜o RE n 899, 2003.Please cite this article in press as: Fonseca-Santos, B. et al., A simple reversed phase
in situ gelling curcumin-loaded liquid crystals in in vitro performance tests. ArabianRichmond, A., 2002. NF-kappa B, chemokine gene transcription and
tumour growth. Nat. Rev. Immunol. 2 (9), 664–674.
Salmazi, R., Calixto, G., Bernegossi, J., dos, M.A., Ramos, S., Bauab,
T.M., et al, 2015. A curcumin-loaded liquid crystal precursor
mucoadhesive system for the treatment of vaginal candidiasis. Int.
J. Nanomed. 10, 4815–4824.
Shah, V.P., 2001. Dissolution: a quality control test vs. a bioequiv-
alence test. Dissolution Technol. 8 (4), 1–2.
Shah, V.P., 2005. IV–IVC for topically applied preparations–a critical
evaluation. Eur. J. Pharm. Biopharm. 60 (2), 309–314.
Shah, V.P., Midha, K.K., Dighe, S., McGilveray, I.J., Skelly, J.P.,
Yacobi, A., et al, 1992. Analytical methods validation: bioavail-
ability, bioequivalence and pharmacokinetic studies. Pharm. Res. 9
(4), 588–592.
Shah, V.P., Siewert, M., Dressman, J., Moeller, H., Brown, C.K.,
2002. Dissolution/in vitro release testing of special dosage forms.
Dissolution Technol. 9 (1), 1–5.
Sharma, R.A., Gescher, A.J., Steward, W.P., 1990. Curcumin: the
story so far. Eur. J. Cancer (Oxford, England: 1990) 41 (13),
1955–1968.
Shojaei, A.H., 1998. Buccal mucosa as a route for systemic drug
delivery: a review. J. Pharm. Pharm. Sci.: Publ. Can. Soc. Pharm.
Sci., Societe canadienne des sciences pharmaceutiques 1 (1), 15–30.
Siewert, M., Dressman, J., Brown, C., Shah, V., Aiache, J.-M.,
Aoyagi, N., et al, 2003. FIP/AAPS guidelines to dissolution/in vitro
release testing of novel/special dosage forms. AAPS PharmSciTech.
4 (1), 43–52.
Silva, H.R.e., Santos, F.K.d., Luz, G.M.d., Chorilli, M., Gremia˜o, M.
P.D., 2014. Validation of high-performance liquid chromato-
graphic method for analysis of ﬂuconazole in microemulsions and
liquid crystals. Braz. J. Pharm. Sci. 50, 381–389.
Silva-Buzanello, R.A.d., Ferro, A.C., Bona, E., Cardozo-Filho, L.,
Arau´jo, PHHd, Leimann, F.V., et al, 2015. Validation of an
Ultraviolet–visible (UV–Vis) technique for the quantitative deter-
mination of curcumin in poly(l-lactic acid) nanoparticles. Food
Chem. 172, 99–104.
Sun, M., Su, X., Ding, B., He, X., Liu, X., Yu, A., et al, 2012.
Advances in nanotechnology-based delivery systems for curcumin.
Nanomedicine 7 (7), 1085–1100.
Syed, H.K., Liew, K.B., Loh, G.O.K., Peh, K.K., 2015. Stability
indicating HPLC–UV method for detection of curcumin in
Curcuma longa extract and emulsion formulation. Food Chem.
170, 321–326.
Thorat, B.N., Jangle, R.D., 2013. Reversed-phase high-performance
liquid chromatography method for analysis of curcuminoids and
curcuminoid-loaded liposome formulation. Indian J. Pharm. Sci.
75 (1), 60.
Ubbink, J., Burbidge, A., Mezzenga, R., 2008. Food structure and
functionality: a soft matter perspective. Soft Matter 4 (8),
1569–1581.
Validation of Analytical Procedures, 2005.
Wichitnithad, W., Jongaroonngamsang, N., Pummangura, S., Rojsit-
thisak, P., 2009. A simple isocratic HPLC method for the
simultaneous determination of curcuminoids in commercial tur-
meric extracts. Phytochem. Anal. 20 (4), 314–319.
Wu, H., Li, X., Liu, W., Chen, T., Li, Y., Zheng, W., et al, 2012.
Surface decoration of selenium nanoparticles by mushroom
polysaccharides-protein complexes to achieve enhanced cellular
uptake and antiproliferative activity. J. Mater. Chem. 22 (19),
9602–9610.
Yu, B., Zhang, Y., Zheng, W., Fan, C., Chen, T., 2012. Positive
surface charge enhances selective cellular uptake and anticancer
efﬁcacy of selenium nanoparticles. Inorg. Chem. 51 (16),
8956–8963.
Zlotogorski, A., Dayan, A., Dayan, D., Chaushu, G., Salo, T., Vered,
M., 2013. Nutraceuticals as new treatment approaches for oral
cancer – I: curcumin. Oral Oncol. 49 (3), 187–191.high-performance liquid chromatography (HPLC) method for determination of
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.014
